Additional Information

Description

Chlorpromazine 25 mg/mL 25x1 mL is an injectable antipsychotic medication primarily used for the management of psychotic disorders, severe behavioral disturbances, and nausea or vomiting that is resistant to standard treatments. It belongs to the phenothiazine class of antipsychotics, which work by modulating neurotransmitter activity in the brain.

The mechanism of action of chlorpromazine involves blocking dopamine (D2) receptors in the brain, particularly in the mesolimbic pathway. This action helps reduce the symptoms of schizophrenia, including delusions and hallucinations, and provides calming effects in cases of acute agitation.

Chlorpromazine is administered intramuscularly or intravenously under medical supervision. Dosage varies based on the condition being treated, the patient’s age, and response to the drug. Potential side effects include sedation, hypotension, extrapyramidal symptoms, and anticholinergic effects such as dry mouth and blurred vision.